Market Overview

Morgan Stanley Reiterates Equal-Weight, Raises Price Target On CDK Global Awaiting More Clarity


In a report published Friday, Morgan Stanley analyst Brian Essex reiterated an Equal-Weight rating on CDK Global (NASDAQ: CDK), and raised the price target from $42.00 to $45.00.

In the report, Morgan Stanley noted, "With management now actively pursuing engagement of a consulting firm, we expect a higher level of multiple support as investors anticipate that operational review could lead to a better long-term margin profile. Remain EW until we get more clarity, but raising TP to $45."

CDK Global closed on Thursday at $47.36.

Latest Ratings for CDK

Aug 2020Morgan StanleyMaintainsOverweight
Jun 2020Morgan StanleyUpgradesEqual-WeightOverweight
May 2020Morgan StanleyMaintainsEqual-Weight

View More Analyst Ratings for CDK
View the Latest Analyst Ratings


Related Articles (CDK)

View Comments and Join the Discussion!

Posted-In: Brian Essex Morgan StanleyAnalyst Color Price Target Analyst Ratings

Latest Ratings

JNJCantor FitzgeraldMaintains200.0
PCTYJMP SecuritiesMaintains220.0
KMBRBC CapitalMaintains147.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at